Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 11/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 11/20 | 0.71 |
| ▸ | MCHR1 | Q99705 | 5/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | ATP4A | P20648 | 2/20 | 0.41 |
| ▸ | ATP4B | P51164 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4878917 | 0.91 | CYP3A4 (0.77) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL4884572 | 0.90 | CYP3A4 (0.58) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL4889001 | 0.89 | CYP3A4 (0.72) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL4888544 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL4882382 | 0.85 | CYP3A4 (0.51) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL4882498 | 0.85 | CYP3A4 (0.52) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL14021372 | 0.83 | CYP3A4 (1.00) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL4888592 | 0.83 | CYP3A4 (0.74) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL14021371 | 0.81 | CYP3A4 (0.81) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 | |
| SCHEMBL14021374 | 0.81 | CYP3A4 (0.85) | CYP3A4CYP2C9MCHR1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311740-A1 | IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2010-12-09 | — | — | US | disclosed |
| US-20100311740-A1 | IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2010-12-09 | — | — | US | disclosed |
| US-20080255358-A1 | Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases | GLAXO GROUP LIMITED (GB) | 2008-10-16 | — | — | US | disclosed |
| US-20080255358-A1 | Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases | GLAXO GROUP LIMITED (GB) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255358-A1 | Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases | ALPI, PYGL, PPIP5K2 | CYP3A4 215/4885CYP2C9 1357/4885MCHR1 3902/4885 |
| US-20100311740-A1 | IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS | HRH2, GIPR, MLNR | CYP3A4 151/4885CYP2C9 585/4885MCHR1 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.